About Event:

The Alaska Hematology Oncology Conference is an accredited continuing education activity designed to improve the care of cancer patients by educating cancer care providers about precision-guided management in hematology and oncology. Regional and national experts in the field will share comprehensive insights into the actionable molecular variations seen in common cancers. The event's format is tailored to promote active learning, enhance knowledge retention, and encourage practitioners to apply fresh insights into their clinical routines. Through didactics, case-centric discussions, and lively Q&A sessions, attendees can gain clarity, address uncertainties, and interact with hematology and oncology experts. This conference aims to provide physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other healthcare professionals with the latest s in precision-guided management in hematology and oncology. It will highlight a multidisciplinary approach and the integration of new advances in patient-centered care. LEARNING OBJECTIVES -Review common molecular abnormalities in various cancers and the optimal timing to test for these abnormalities. -Interpret the findings from next-generation sequencing and other biomarkers that indicate the likelihood of response to specific therapies while also understanding the inherent challenges. -Apply optimal strategies centered on molecular-targeted treatments in the management of patients with cancer. -Summarize emerging research, the mechanism of action, and the significance of new molecular-targeted treatments in managing cancer patients.